You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hec585

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • HEC585
  • +2 more
  • Shanghai, China
    Shanghai Xuhui Central Hospital
May 12, 2022

Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, )

Completed
  • Idiopathic Pulmonary Fibrosis
  • HEC585
  • placebo
  • Shanghai, China
    Shanghai Xuhui Central Hospital
Mar 14, 2022

Progressive Fibrosing Interstitial Lung Disease Trial in Beijing (HEC585, Placebo)

Not yet recruiting
  • Progressive Fibrosing Interstitial Lung Disease
  • HEC585
  • Placebo
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Nov 30, 2021

Idiopathic Pulmonary Fibrosis Trial in Beijing (HEC585, Pirfenidone, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • HEC585
  • +2 more
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Sep 18, 2021

Idiopathic Pulmonary Fibrosis Trial in Madison (HEC585)

Completed
  • Idiopathic Pulmonary Fibrosis
  • HEC585
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
Jul 23, 2020